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AUTOMATED, MINIATURIZED INSTRUMENT FOR SPACE BIOLOGY APPLICATIONS AND THE
MONITORING OF THE ASTRONAUT’S HEALTH ONBOARD THE ISS
Abstract
Human space travelers experience a unique environment that aﬀects homeostasis and physiologic
adaptation. The spacecraft environment subjects the traveler to noise, chemical and microbiological
contaminants, increased radiation, and variable gravity forces. As humans prepare for long-duration
missions to the International Space Station (ISS) and beyond, eﬀective measures must be developed,
veriﬁed and implemented to ensure mission success. Limited biomedical quantitative capabilities are
currently available onboard the ISS. Therefore, the development of versatile instruments to perform space
biological analysis and to monitor astronauts’ health is needed.
We are developing a fully automated, miniaturized system for measuring gene expression on small
spacecraft in order to better understand the inﬂuence of the space environment on biological systems. This
low-cost, low-power, multi-purpose instrument represents a major scientiﬁc and technological advancement
by providing data on cellular metabolism and regulation. The current system will support growth of
microorganisms, extract and purify the RNA, hybridize it to the array, read the expression levels of a
large number of genes by microarray analysis, and transmit the measurements to Earth. The system
will help discover how bacteria develop resistance to antibiotics and how pathogenic bacteria sometimes
increase their virulence in space, facilitating the development of adequate countermeasures to decrease
risks associated with human spaceﬂight.
The current stand-alone technology could be used as an integrated platform onboard the ISS to per-
form similar genetic analyses on any biological systems from the tree of life. Additionally, with some
modiﬁcation the system could be implemented to perform real-time in-situ microbial monitoring of the
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ISS environment (air, surface and water samples) and the astronaut’s microbiome using 16SrRNA mi-
croarray technology. Furthermore, the current system can be enhanced substantially by combining it
with other technologies for automated, miniaturized, high-throughput biological measurements, such as
fast sequencing, protein identiﬁcation (proteomics) and metabolite proﬁling (metabolomics). Thus, the
system can be integrated with other biomedical instruments in order to support and enhance telemedicine
capability onboard ISS.
NASA’s mission includes sustained investment in critical research leading to eﬀective countermeasures
to minimize the risks associated with human spaceﬂight, and the use of appropriate technology to sustain
space exploration at reasonable cost. Our integrated microarray technology is expected to fulﬁll these
two critical requirements and to enable the scientiﬁc community to better understand and monitor the
eﬀects of the space environment on microorganisms and on the astronaut, in the process leveraging current
capabilities and overcoming present limitations.
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